{"nctId":"NCT01521845","briefTitle":"Study of the Effect of omega3 on Biomarkers of Cardiac Necrosis (CKMB and Troponin I) and Inflammation Marker (CRP) After Elective Percutaneous Coronary Intervention (PCI)","startDateStruct":{"date":"2012-01"},"conditions":["Coronary Arteriosclerosis"],"count":104,"armGroups":[{"label":"omega 3","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: omega 3"]},{"label":"control","type":"NO_INTERVENTION","interventionNames":[]}],"interventions":[{"name":"omega 3","otherNames":["fish oil"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* candidate of elective PCI\n* treatment with aspirin at least 5 days before PCI\n\nExclusion Criteria:\n\n* high CKMB and troponin I level\n* cardiac bypass in recent 3 months\n* platelet count \\< 70Ã—10 9/L\n* sever chronic renal failure\n* active bleeding\n* treatment with glycoprotein IIb/IIIa inhibitors during PCI\n* treatment with bivalirudin during PCI\n* sensitivity to aspirin and clopidogrel","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Cardiac Necrosis Biomarkers (CKMB, Troponin I)","description":"difference between study and control group in 8 and 24 hrs after percutaneous coronary intervention","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13","spread":null},{"groupId":"OG001","value":"18","spread":null}]}]}]},{"type":"PRIMARY","title":"Inflammation Marker (CRP)","description":"difference between study and control group in 8 and 24 hrs after percutaneous coronary intervention","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"6","spread":null}]}]}]},{"type":"SECONDARY","title":"MACE(Major Adverse Cardiac Effect) Defined as Need for Target Revascularization, Myocardial Infarction and Death","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":43},"commonTop":[]}}}